Literature DB >> 15155991

A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria.

Emmanuel C Emukah1, Edith Osuoha, Emmanuel S Miri, Jude Onyenama, Uche Amazigo, Christopher Obijuru, Nkeiru Osuji, Josephine Ekeanyanwu, Stanley Amadiegwu, Kenneth Korve, Frank O Richards.   

Abstract

We conducted a cohort study on impact of effects of eight years of annual ivermectin mass treatment administered in eight villages in Imo State, Nigeria. Physical and visual acuity examinations carried out in 462 persons in 1995, prior to the launching of mass drug administration with ivermectin, were compared with re-examinations of 411 (89%) of these same individuals in 2002. We found that gross visual impairment decreased from 16% to 1%, nodule prevalence decreased from 59% to 18%, and papular dermatitis was reduced from 15% to 2%. No change was seen in leopard skin rates (14%). The only incident lesions were three subjects from a single community having the appearance of new nodules (e.g., nodules not identified in the 1995 examinations). Differences in community coverage did not appear to influence the benefit from treatment of individual residents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155991

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Effects of annual mass treatment with ivermectin for onchocerciasis on the prevalence of intestinal helminths.

Authors:  Julie Gutman; Emmanuel Emukah; Njideka Okpala; Chinyere Okoro; Andrew Obasi; Emmanuel S Miri; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

2.  Modeling targeted ivermectin treatment for controlling river blindness.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

3.  Community-wide distribution of long-lasting insecticidal nets can halt transmission of lymphatic filariasis in southeastern Nigeria.

Authors:  Frank O Richards; Emmanuel Emukah; Patricia M Graves; Omeni Nkwocha; Lawrence Nwankwo; Lindsay Rakers; Aryc Mosher; Amy Patterson; Masayo Ozaki; Bertram E B Nwoke; Chinyere N Ukaga; Chidiebere Njoku; Kenrick Nwodu; Andrew Obasi; Emmanuel S Miri
Journal:  Am J Trop Med Hyg       Date:  2013-08-12       Impact factor: 2.345

4.  Impact of Eighteen-Year Varied Compliance to Onchocerciasis Treatment with Ivermectin in Sentinel Savannah Agrarian Communities in Kaduna State of Nigeria.

Authors:  Hudu O Osue; Helen I Inabo; Sabo E Yakubu; Patrick A Audu; Musa Galadima; Lillian E Odama; Danjuma Musa; Saleh A Ado; Mohammed Mamman
Journal:  ISRN Parasitol       Date:  2013-08-25

5.  Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.

Authors:  Hudu O Osue
Journal:  Ethiop J Health Sci       Date:  2017-03

6.  How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

Authors:  Natalie V S Vinkeles Melchers; Wilma A Stolk; Michele E Murdoch; Belén Pedrique; Marielle Kloek; Roel Bakker; Sake J de Vlas; Luc E Coffeng
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11

7.  Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Authors:  Sébastien D S Pion; Hugues C Nana-Djeunga; Joseph Kamgno; Nicholas Tendongfor; Samuel Wanji; Flobert Njiokou; Roger K Prichard; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

8.  Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.

Authors:  Hugo C Turner; Martin Walker; Thomas S Churcher; María-Gloria Basáñez
Journal:  Parasit Vectors       Date:  2014-05-26       Impact factor: 3.876

9.  Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.

Authors:  Robert Colebunders; Michel Mandro; John L Mokili; Gisele Mucinya; Germain Mambandu; Kenneth Pfarr; Ingrid Reiter-Owona; Achim Hoerauf; Floribert Tepage; Bethanie Levick; Michael Begon; Anne Laudisoit
Journal:  Int J Infect Dis       Date:  2016-05-19       Impact factor: 3.623

10.  Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia.

Authors:  Abdi Samuel; Tariku Belay; Delenasaw Yehalaw; Mohammed Taha; Endalew Zemene; Ahmed Zeynudin
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.